Array ( [PREVIEW_PICTURE] => Array ( [ID] => 78202 [TIMESTAMP_X] => 19.11.2025 19:50:04 [MODULE_ID] => iblock [HEIGHT] => 733 [WIDTH] => 1100 [FILE_SIZE] => 68784 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/711 [FILE_NAME] => 711a04dfe81e2f8a66b80aaa386f7b8b.jpg [ORIGINAL_NAME] => euthanasia.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 0bc006996b9e5669b055c3fbcef33623 [~src] => [SRC] => /upload/iblock/711/711a04dfe81e2f8a66b80aaa386f7b8b.jpg [ALT] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака [TITLE] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака ) [~PREVIEW_PICTURE] => 78202 [ID] => 39664 [~ID] => 39664 [NAME] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака [~NAME] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака [IBLOCK_ID] => 2 [~IBLOCK_ID] => 2 [IBLOCK_SECTION_ID] => 2 [~IBLOCK_SECTION_ID] => 2 [DETAIL_TEXT] => Общество онкологии Кипра (OEK) разъяснило свою позицию в среду относительно одобрения запросов на лекарства для лечения рака со стороны Организации медицинского страхования (HIO) на фоне жалоб на задержки в предоставлении лечения.

OEK рассмотрело процедурные вопросы и задержки, связанные с передачей комитета по номинальным запросам из Министерства здравоохранения в HIO, которая произошла ещё в мае.

Оно активно участвовало в консультациях, направленных на ускорение и улучшение процесса одобрения.

На прошлой встрече между OEK и HIO 26 мая обе стороны согласовали научно обоснованные сроки обновления и завершения терапевтических протоколов.

Обновление этих протоколов, как и ожидалось, уже привело к сокращению количества номинальных запросов, сообщило OEK.

Далее было подчёркнуто, что в случае отклонения запроса лечащие врачи имеют право обратиться в апелляционный совет.

Успокаивая пациентов, OEK отметило, что новые критерии применяются прозрачно и серьёзно, и что оно продолжает внимательно следить за прогрессом системы и при необходимости предпримет дальнейшие действия.

Ранее в мае были рассмотрены препятствия в процессе утверждения онкологических препаратов на фоне растущих жалоб врачей и пациентов на критические задержки. Сообщалось, что онкологи сталкивались с отказами или молчанием после подачи срочных запросов на эти препараты. [~DETAIL_TEXT] => Общество онкологии Кипра (OEK) разъяснило свою позицию в среду относительно одобрения запросов на лекарства для лечения рака со стороны Организации медицинского страхования (HIO) на фоне жалоб на задержки в предоставлении лечения.

OEK рассмотрело процедурные вопросы и задержки, связанные с передачей комитета по номинальным запросам из Министерства здравоохранения в HIO, которая произошла ещё в мае.

Оно активно участвовало в консультациях, направленных на ускорение и улучшение процесса одобрения.

На прошлой встрече между OEK и HIO 26 мая обе стороны согласовали научно обоснованные сроки обновления и завершения терапевтических протоколов.

Обновление этих протоколов, как и ожидалось, уже привело к сокращению количества номинальных запросов, сообщило OEK.

Далее было подчёркнуто, что в случае отклонения запроса лечащие врачи имеют право обратиться в апелляционный совет.

Успокаивая пациентов, OEK отметило, что новые критерии применяются прозрачно и серьёзно, и что оно продолжает внимательно следить за прогрессом системы и при необходимости предпримет дальнейшие действия.

Ранее в мае были рассмотрены препятствия в процессе утверждения онкологических препаратов на фоне растущих жалоб врачей и пациентов на критические задержки. Сообщалось, что онкологи сталкивались с отказами или молчанием после подачи срочных запросов на эти препараты. [DETAIL_TEXT_TYPE] => html [~DETAIL_TEXT_TYPE] => html [PREVIEW_TEXT] => Общество онкологии Кипра (OEK) разъяснило свою позицию в среду относительно одобрения... [~PREVIEW_TEXT] => Общество онкологии Кипра (OEK) разъяснило свою позицию в среду относительно одобрения... [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [DETAIL_PICTURE] => Array ( [SRC] => /upload/resize_cache/iblock/711/600_400_1/711a04dfe81e2f8a66b80aaa386f7b8b.jpg [WIDTH] => 600 [HEIGHT] => 399 ) [~DETAIL_PICTURE] => 78203 [ACTIVE_FROM] => 19.11.2025 19:50:00 [~ACTIVE_FROM] => 19.11.2025 19:50:00 [LIST_PAGE_URL] => /news/ [~LIST_PAGE_URL] => /news/ [DETAIL_PAGE_URL] => /news/society/oncology-society-responds-to-cancer-drug-approval-delays/ [~DETAIL_PAGE_URL] => /news/society/oncology-society-responds-to-cancer-drug-approval-delays/ [LANG_DIR] => / [~LANG_DIR] => / [CODE] => oncology-society-responds-to-cancer-drug-approval-delays [~CODE] => oncology-society-responds-to-cancer-drug-approval-delays [EXTERNAL_ID] => 39664 [~EXTERNAL_ID] => 39664 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => infoportal_news_s1 [~IBLOCK_CODE] => infoportal_news_s1 [IBLOCK_EXTERNAL_ID] => infoportal_news_s1 [~IBLOCK_EXTERNAL_ID] => infoportal_news_s1 [LID] => s1 [~LID] => s1 [NAV_RESULT] => [DISPLAY_ACTIVE_FROM] => 19 Ноября 2025 [IPROPERTY_VALUES] => Array ( ) [FIELDS] => Array ( [PREVIEW_PICTURE] => Array ( [ID] => 78202 [TIMESTAMP_X] => 19.11.2025 19:50:04 [MODULE_ID] => iblock [HEIGHT] => 733 [WIDTH] => 1100 [FILE_SIZE] => 68784 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/711 [FILE_NAME] => 711a04dfe81e2f8a66b80aaa386f7b8b.jpg [ORIGINAL_NAME] => euthanasia.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 0bc006996b9e5669b055c3fbcef33623 [~src] => [SRC] => /upload/iblock/711/711a04dfe81e2f8a66b80aaa386f7b8b.jpg [ALT] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака [TITLE] => Онкологическое общество реагирует на задержки с одобрением лекарств от рака ) ) [PROPERTIES] => Array ( [ORIGINAL_URL] => Array ( [ID] => 51 [TIMESTAMP_X] => 2017-10-03 13:37:23 [IBLOCK_ID] => 2 [NAME] => Ссылка на сайте-источнике [ACTIVE] => Y [SORT] => 10 [CODE] => ORIGINAL_URL [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125821 [VALUE] => /2025/11/19/oncology-society-responds-to-cancer-drug-approval-delays [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => /2025/11/19/oncology-society-responds-to-cancer-drug-approval-delays [~DESCRIPTION] => [~NAME] => Ссылка на сайте-источнике [~DEFAULT_VALUE] => ) [THEME_EN] => Array ( [ID] => 280 [TIMESTAMP_X] => 2025-01-08 18:01:42 [IBLOCK_ID] => 2 [NAME] => Тема (en) [ACTIVE] => Y [SORT] => 20 [CODE] => THEME_EN [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125823 [VALUE] => Oncology society responds to cancer drug approval delays [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Oncology society responds to cancer drug approval delays [~DESCRIPTION] => [~NAME] => Тема (en) [~DEFAULT_VALUE] => ) [TEXT_EN] => Array ( [ID] => 281 [TIMESTAMP_X] => 2025-01-08 18:01:42 [IBLOCK_ID] => 2 [NAME] => Текст новости (en) [ACTIVE] => Y [SORT] => 40 [CODE] => TEXT_EN [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => HTML [USER_TYPE_SETTINGS] => Array ( [height] => 200 ) [HINT] => [PROPERTY_VALUE_ID] => 125824 [VALUE] => Array ( [TEXT] => The Cyprus Oncology Society (OEK) clarified its position on Wednesday regarding the approval of requests for cancer treatment drugs by the Health Insurance Organisation (HIO), amid complains of delays the availability of treatment. OEK addressed procedural issues and delays linked to [the transfer of the nominal requests committee](https://cyprus-mail.com/2025/05/08/mps-demand-urgent-action-on-cancer-drug-delays) from the Health Ministry to the HIO which took place back in May. It actively participated in consultations aimed at accelerating and improving the approval process. A past meeting between OEK and HIO on May 26, saw both parties agreeing on a scientifically accepted timeline for the update and completion of therapeutic protocols. Updating these protocols has already led, as expected, to a reduction in the number of nominal requests, said OEK. It went on to emphasise that if a request is rejected, treating physicians have the right to appeal to the review board. Reassuring patients that the new criteria are applied with transparency and seriousness, it noted that it continues to closely monitor the progress of the system and will undertake further interventions if necessary. Earlier in May, obstacles in the approval process for oncology drugs were examined, amid rising complaints from doctors and patients about critical delays. Oncologists had reportedly faced rejections or silence after submitting urgent requests for these drugs. [TYPE] => HTML ) [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [TEXT] => The Cyprus Oncology Society (OEK) clarified its position on Wednesday regarding the approval of requests for cancer treatment drugs by the Health Insurance Organisation (HIO), amid complains of delays the availability of treatment. OEK addressed procedural issues and delays linked to [the transfer of the nominal requests committee](https://cyprus-mail.com/2025/05/08/mps-demand-urgent-action-on-cancer-drug-delays) from the Health Ministry to the HIO which took place back in May. It actively participated in consultations aimed at accelerating and improving the approval process. A past meeting between OEK and HIO on May 26, saw both parties agreeing on a scientifically accepted timeline for the update and completion of therapeutic protocols. Updating these protocols has already led, as expected, to a reduction in the number of nominal requests, said OEK. It went on to emphasise that if a request is rejected, treating physicians have the right to appeal to the review board. Reassuring patients that the new criteria are applied with transparency and seriousness, it noted that it continues to closely monitor the progress of the system and will undertake further interventions if necessary. Earlier in May, obstacles in the approval process for oncology drugs were examined, amid rising complaints from doctors and patients about critical delays. Oncologists had reportedly faced rejections or silence after submitting urgent requests for these drugs. [TYPE] => HTML ) [~DESCRIPTION] => [~NAME] => Текст новости (en) [~DEFAULT_VALUE] => ) [FORUM_MESSAGE_CNT] => Array ( [ID] => 2 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Количество комментариев к элементу [ACTIVE] => Y [SORT] => 500 [CODE] => FORUM_MESSAGE_CNT [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 63 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Количество комментариев к элементу [~DEFAULT_VALUE] => ) [FORUM_TOPIC_ID] => Array ( [ID] => 3 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Тема форума для комментариев [ACTIVE] => Y [SORT] => 500 [CODE] => FORUM_TOPIC_ID [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 62 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Тема форума для комментариев [~DEFAULT_VALUE] => ) [MORE_PHOTO] => Array ( [ID] => 4 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Изображения [ACTIVE] => Y [SORT] => 500 [CODE] => MORE_PHOTO [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 58 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Изображения [~DEFAULT_VALUE] => ) [PARTMAIN] => Array ( [ID] => 5 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Главная новость раздела [ACTIVE] => Y [SORT] => 500 [CODE] => PARTMAIN [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 56 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Главная новость раздела [~DEFAULT_VALUE] => ) [MAIN] => Array ( [ID] => 6 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Главная новость главной страницы [ACTIVE] => Y [SORT] => 500 [CODE] => MAIN [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 55 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Главная новость главной страницы [~DEFAULT_VALUE] => ) [THEME] => Array ( [ID] => 7 [TIMESTAMP_X] => 2015-04-24 10:27:06 [IBLOCK_ID] => 2 [NAME] => Тема [ACTIVE] => Y [SORT] => 500 [CODE] => THEME [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 54 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 1 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => EAutocomplete [USER_TYPE_SETTINGS] => Array ( [VIEW] => A [SHOW_ADD] => Y [MAX_WIDTH] => 250 [MIN_HEIGHT] => 24 [MAX_HEIGHT] => 1000 [BAN_SYM] => ,; [REP_SYM] => [OTHER_REP_SYM] => [IBLOCK_MESS] => Y ) [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Тема [~DEFAULT_VALUE] => ) [LINK_SOURCE] => Array ( [ID] => 8 [TIMESTAMP_X] => 2015-05-25 16:39:08 [IBLOCK_ID] => 2 [NAME] => Источник [ACTIVE] => Y [SORT] => 500 [CODE] => LINK_SOURCE [DEFAULT_VALUE] => russiancyprus [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 53 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125820 [VALUE] => cyprus-mail.com [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => cyprus-mail.com [~DESCRIPTION] => [~NAME] => Источник [~DEFAULT_VALUE] => russiancyprus ) [IS_SENT_TO_CHANEL] => Array ( [ID] => 167 [TIMESTAMP_X] => 2020-06-25 17:42:19 [IBLOCK_ID] => 2 [NAME] => Is sent to telegram [ACTIVE] => Y [SORT] => 500 [CODE] => IS_SENT_TO_CHANEL [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125827 [VALUE] => 1 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 1 [~DESCRIPTION] => [~NAME] => Is sent to telegram [~DEFAULT_VALUE] => ) [YANDEX_TASK_ID_THEME] => Array ( [ID] => 285 [TIMESTAMP_X] => 2025-01-20 21:25:08 [IBLOCK_ID] => 2 [NAME] => YANDEX TASK ID FOR THEME [ACTIVE] => Y [SORT] => 900 [CODE] => YANDEX_TASK_ID_THEME [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125825 [VALUE] => d7q8j0nfi69p24d5fcaj [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => d7q8j0nfi69p24d5fcaj [~DESCRIPTION] => [~NAME] => YANDEX TASK ID FOR THEME [~DEFAULT_VALUE] => ) [YANDEX_TASK_ID] => Array ( [ID] => 284 [TIMESTAMP_X] => 2025-01-20 20:37:32 [IBLOCK_ID] => 2 [NAME] => YANDEX TASK ID [ACTIVE] => Y [SORT] => 1000 [CODE] => YANDEX_TASK_ID [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 125826 [VALUE] => d7q261o2davucd0047uj [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => d7q261o2davucd0047uj [~DESCRIPTION] => [~NAME] => YANDEX TASK ID [~DEFAULT_VALUE] => ) ) [DISPLAY_PROPERTIES] => Array ( ) [IBLOCK] => Array ( [ID] => 2 [~ID] => 2 [TIMESTAMP_X] => 20.01.2025 22:57:06 [~TIMESTAMP_X] => 20.01.2025 22:57:06 [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [LID] => s1 [~LID] => s1 [CODE] => infoportal_news_s1 [~CODE] => infoportal_news_s1 [NAME] => Новости [~NAME] => Новости [ACTIVE] => Y [~ACTIVE] => Y [SORT] => 500 [~SORT] => 500 [LIST_PAGE_URL] => /news/ [~LIST_PAGE_URL] => /news/ [DETAIL_PAGE_URL] => #SITE_DIR#/news/#SECTION_CODE#/#CODE#/ [~DETAIL_PAGE_URL] => #SITE_DIR#/news/#SECTION_CODE#/#CODE#/ [SECTION_PAGE_URL] => #SITE_DIR#/news/#CODE#/ [~SECTION_PAGE_URL] => #SITE_DIR#/news/#CODE#/ [PICTURE] => [~PICTURE] => [DESCRIPTION] => [~DESCRIPTION] => [DESCRIPTION_TYPE] => text [~DESCRIPTION_TYPE] => text [RSS_TTL] => 24 [~RSS_TTL] => 24 [RSS_ACTIVE] => Y [~RSS_ACTIVE] => Y [RSS_FILE_ACTIVE] => N [~RSS_FILE_ACTIVE] => N [RSS_FILE_LIMIT] => 0 [~RSS_FILE_LIMIT] => 0 [RSS_FILE_DAYS] => 0 [~RSS_FILE_DAYS] => 0 [RSS_YANDEX_ACTIVE] => N [~RSS_YANDEX_ACTIVE] => N [XML_ID] => infoportal_news_s1 [~XML_ID] => infoportal_news_s1 [TMP_ID] => adf9113ce97738184efe133d53e3d656 [~TMP_ID] => adf9113ce97738184efe133d53e3d656 [INDEX_ELEMENT] => Y [~INDEX_ELEMENT] => Y [INDEX_SECTION] => N [~INDEX_SECTION] => N [WORKFLOW] => N [~WORKFLOW] => N [BIZPROC] => N [~BIZPROC] => N [SECTION_CHOOSER] => L [~SECTION_CHOOSER] => L [LIST_MODE] => [~LIST_MODE] => [RIGHTS_MODE] => S [~RIGHTS_MODE] => S [SECTION_PROPERTY] => [~SECTION_PROPERTY] => [PROPERTY_INDEX] => [~PROPERTY_INDEX] => [VERSION] => 1 [~VERSION] => 1 [LAST_CONV_ELEMENT] => 0 [~LAST_CONV_ELEMENT] => 0 [SOCNET_GROUP_ID] => [~SOCNET_GROUP_ID] => [EDIT_FILE_BEFORE] => [~EDIT_FILE_BEFORE] => [EDIT_FILE_AFTER] => [~EDIT_FILE_AFTER] => [SECTIONS_NAME] => Разделы [~SECTIONS_NAME] => Разделы [SECTION_NAME] => Раздел [~SECTION_NAME] => Раздел [ELEMENTS_NAME] => Новости [~ELEMENTS_NAME] => Новости [ELEMENT_NAME] => Новость [~ELEMENT_NAME] => Новость [EXTERNAL_ID] => infoportal_news_s1 [~EXTERNAL_ID] => infoportal_news_s1 [LANG_DIR] => / [~LANG_DIR] => / [SERVER_NAME] => russiancyprus.news [~SERVER_NAME] => russiancyprus.news ) [SECTION] => Array ( [PATH] => Array ( [0] => Array ( [ID] => 2 [~ID] => 2 [TIMESTAMP_X] => 2025-01-20 22:54:27 [~TIMESTAMP_X] => 2025-01-20 22:54:27 [MODIFIED_BY] => 1 [~MODIFIED_BY] => 1 [DATE_CREATE] => 2015-04-24 10:15:32 [~DATE_CREATE] => 2015-04-24 10:15:32 [CREATED_BY] => 1 [~CREATED_BY] => 1 [IBLOCK_ID] => 2 [~IBLOCK_ID] => 2 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [ACTIVE] => Y [~ACTIVE] => Y [GLOBAL_ACTIVE] => Y [~GLOBAL_ACTIVE] => Y [SORT] => 5 [~SORT] => 5 [NAME] => Общество и политика [~NAME] => Общество и политика [PICTURE] => [~PICTURE] => [LEFT_MARGIN] => 1 [~LEFT_MARGIN] => 1 [RIGHT_MARGIN] => 2 [~RIGHT_MARGIN] => 2 [DEPTH_LEVEL] => 1 [~DEPTH_LEVEL] => 1 [DESCRIPTION] => [~DESCRIPTION] => [DESCRIPTION_TYPE] => text [~DESCRIPTION_TYPE] => text [SEARCHABLE_CONTENT] => Общество и политика [~SEARCHABLE_CONTENT] => Общество и политика [CODE] => society [~CODE] => society [XML_ID] => 111 [~XML_ID] => 111 [TMP_ID] => [~TMP_ID] => [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SOCNET_GROUP_ID] => [~SOCNET_GROUP_ID] => [LIST_PAGE_URL] => /news/ [~LIST_PAGE_URL] => /news/ [SECTION_PAGE_URL] => /news/society/ [~SECTION_PAGE_URL] => /news/society/ [IBLOCK_TYPE_ID] => news [~IBLOCK_TYPE_ID] => news [IBLOCK_CODE] => infoportal_news_s1 [~IBLOCK_CODE] => infoportal_news_s1 [IBLOCK_EXTERNAL_ID] => infoportal_news_s1 [~IBLOCK_EXTERNAL_ID] => infoportal_news_s1 [EXTERNAL_ID] => 111 [~EXTERNAL_ID] => 111 [IPROPERTY_VALUES] => Array ( ) ) ) ) [SECTION_URL] => /news/society/ [ITEMS_THEME] => Array ( ) )